Jinxin Fertility Group IPO:Â Valuation Reasonable for the Trade-Offs
Jinxin Fertility Co Ltd (1951 HK)Â is a leading assisted reproductive service (ARS) provider in China and the US. It announced its IPO price...
1.2k Views
Jinxin Fertility (锦欣生殖) Pre-IPO: Strong Foothold in Sichuan but Weak Sentiment for Sector
Jinxin Fertility, a leading privately owned assisted reproductive service provider in China and the US, refiled to list in Hong Kong. Per news...
1.5k Views
Guangdong Kanghua IPO: Ask About Future Loans to Related Parties
Decreasing Debt Level – Good at First Look Taking a look at GDKH balance sheet, we can see that its bank borrowings (no. 24) have decreased from a...
505 Views
Guangdong Kanghua IPO:Â Concentration Risk and More Track Record Needed
Guangdong Kanghua (GDKH) has one of the largest for-profit private hospital in China (Kanghua hospital) in terms of registered beds and third...
440 Views
Kangning Hospital IPO: Unique? Yes. Deserving of a Premium? No.
Following our fellow healthcare expert Kemp's note on Wenzhou Kangning Hospital, the company recently launched its IPO to raise US$73-88m for...
509 Views